Publications by authors named "Christophe Fermé"

62Publications

[Hodgkin lymphoma: Current and future therapeutic strategies].

Bull Cancer 2018 Jan 27;105(1):81-98. Epub 2017 Dec 27.

Cancer campus Grand-Paris, Gustave-Roussy cancer comprehensive center, département d'hématologie, 114, rue Édouard-Vaillant, 94805 Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2017.11.008DOI Listing
January 2018

Challenges and perspectives in the immunotherapy of Hodgkin lymphoma.

Eur J Cancer 2017 11 9;85:67-77. Epub 2017 Sep 9.

Département des Innovations Thérapeutiques et des Essais Précoces, Gustave Roussy, 114 Rue Edouard-Vaillant, F-94805 Villejuif, France; Département d'Oncologie Médicale, Institut Jules Bordet, rue Héger Bordet 1, B-1000 Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.08.014DOI Listing
November 2017

Poor predictive value of positive interim FDG-PET/CT in primary mediastinal large B-cell lymphoma.

Eur J Nucl Med Mol Imaging 2017 Nov 21;44(12):2018-2024. Epub 2017 Jun 21.

Department of Hematology, Gustave Roussy and Université Paris Saclay, 114 Rue Edouard Vaillant, 94805, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-017-3758-5DOI Listing
November 2017

Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial.

J Clin Oncol 2017 Jun 14;35(16):1786-1794. Epub 2017 Mar 14.

Marc P.E. André, Université Catholique de Louvain, Yvoir; Catherine Fortpied, Valeria Fiaccadori, and Tiana Raveloarivahy, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Théodore Girinsky and Christophe Fermé, Institut Gustave Roussy, Villejuif; Oumédaly Reman, Institut d'Hématologie de Basse Normandie, Centre Hospitalier Universitaire, Caen; Pauline Brice, Assistance Publique des Hopitaux de Paris Hôpital Saint-Louis; Richard Delarue, Assistance Publique des Hopitaux de Paris Hôpital Universitaire Necker-Enfants Maladies, Paris; Olivier Casasnovas, Centre Hospitalier Universitaire le Bocage and Institut National de la Santé et de la Recherche Médicale, Dijon; Véronique Edeline, Hôpital René Hugenin-Institut Curie, Saint Cloud; Réda Bouabdallah, Institut Paoli Calmette, Marseille; Catherine Sebban, Hematology Centre Léon Bérard, Lyon; Aspasia Stamatoullas, Centre Henri Becquerel, Rouen; Michel Meignan, Henri Mondor University Hospitals, Créteil, France; Massimo Federico and Monica Bellei, University of Modena and Reggio Emilia, Modena; Manuel Gotti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia; Alessandro Re, Spedali Civili Hospital, Brescia; Francesco Merli and Annibale Versari, Arcispedale Santa Maria Nuova Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy; Richard van der Maazen and John Raemaekers, Radboud University Medical Center, Nijmegen; Gustaaf van Imhoff, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands; and Lena Specht and Martin Hutchings, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.6394DOI Listing
June 2017

[Consortium for detection and management of lung damage induced by bleomycin].

Bull Cancer 2016 Jul-Aug;103(7-8):651-61. Epub 2016 May 27.

Gustave-Roussy, département de médecine oncologique, 114, rue Édouard-Vaillant, 94800 Villejuif, France; Université Paris Descartes, UFR des sciences pharmaceutiques et biologiques, 75270 Paris cedex 06, France; Gustave-Roussy, département des innovations thérapeutiques et des essais précoces, 114, rue Édouard-Vaillant, 94800 Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2016.04.005DOI Listing
January 2017

Eight Cycles of ABVD Versus Four Cycles of BEACOPPescalated Plus Four Cycles of BEACOPPbaseline in Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial.

J Clin Oncol 2016 06 25;34(17):2028-36. Epub 2016 Apr 25.

Patrice Carde and Christophe Ferme, Gustave Roussy Cancer Campus, Villejuif; Pauline Brice, Hopital St. Louis, Paris; Olivier Casasnovas and Denis Caillot, Centre Hospitalier Universitaire (CHU) de Dijon, Dijon; Isabelle Gaillard, CHU Henri Mondor, Creteil; Serge Bologna, Centre Hospitalier Regional Universitaire (CHR) de Nancy, Nancy; Frank Morschhauser, CHR de Lille, Lille; Bertrand Coiffier, CHU de Lyon, Lyon; Nicolas Mounier, Hopital de L'Archet, Nice, France; Matthias Karrasch and Catherine Fortpied, European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium; Hussein Khaled, National Cancer Institute, Cairo, Egypt; Pieternella Johanna Lugtenburg, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Igor Aurer, University Hospital Centre Zagreb, Zagreb, Croatia; Ralph Meyer, Juravinski Cancer Centre, Hamilton, Ontario; Matthew Seftel, Cancer Care Manitoba, Winnipeg, Manitoba, Canada; Max Wolf, Peter MacCallum Cancer Institute, East Melbourne, Victoria, Australia; Bengt Glimelius, Uppsala University, Uppsala, Sweden; and Anna Sureda, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.5648DOI Listing
June 2016

Young patients with non-germinal center B-cell-like diffuse large B-cell lymphoma benefit from intensified chemotherapy with ACVBP plus rituximab compared with CHOP plus rituximab: analysis of data from the Groupe d'Etudes des Lymphomes de l'Adulte/lymphoma study association phase III trial LNH 03-2B.

J Clin Oncol 2014 Dec 10;32(35):3996-4003. Epub 2014 Nov 10.

Thierry Jo Molina, Danielle Canioni, and Jean-Philippe Jais, Assistance Publique-Hôpitaux de Paris (AP-HP), Necker Enfants-Malades, Université Paris Descartes, EA 7324, Sorbonne Paris Cité; Josette Brière and Catherine Thieblemont, AP-HP, Saint-Louis, Université Paris Diderot, Sorbonne Paris Cité; Catherine Thieblemont, L'Institut National de la Santé et de la Recherche Médicale (INSERM) U728; Bettina Fabiani, AP-HP, Saint-Antoine, Paris; Christiane Copie-Bergman, Corinne Haioun, Karen Leroy, and Philippe Gaulard, AP-HP, Groupe Hospitalier Henri-Mondor/Albert-Chenevier, Université Paris-Est Créteil; Christiane Copie-Bergman, Karen Leroy, and Philippe Gaulard, INSERM Unité U955 Équipe 9, Créteil; Christian Recher, Centre Hospitalier Universitaire (CHU) Purpan, Université Toulouse III Paul Sabatier, Toulouse; Françoise Berger, Gilles Salles, and Bertrand Coiffier, Hospices Civils de Lyon, Université Claude Bernard, Pierre-Bénite; Christophe Fermé, Institut Gustave Roussy, Villejuif; Marie-Christine Copin and Franck Morschauser, CHU Lille, Lille; Olivier Casasnovas and Tony Petrella, CHU Dijon, Dijon; Nicolas Mounier, CHU Nice, Nice; and Fabrice Jardin and Hervé Tilly, Centre Henri Becquerel, Université de Rouen, Rouen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.54.9493DOI Listing
December 2014

Sarcoidosis occurring after lymphoma: report of 14 patients and review of the literature.

Medicine (Baltimore) 2014 Nov;93(21):e121

Department of Internal Medicine (JL, CLL, LG, NC-C, LM, BT), National Referral Center for Rare Systemic and Autoimmune Diseases; Department of Hematology (BD), Cochin Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Descartes; Department of Hematology (EC); Department of Internal Medicine (CC-A), Pitié-Salpêtrière Hospital, AP-HP; Department of Onco-Hematology (PB), Saint-Louis Hospital, AP-HP; Department of Pathology (BB), Hôtel-Dieu Hospital, AP-HP; Department of Thoracic Surgery (MA), Cochin Hospital, AP-HP, Paris; Department of Internal Medicine (AC, FM), Belle Isle Hospital, Metz; Department of Internal Medicine (AG, NS), CHU Conception, Assistance Publique-Hôpitaux de Marseille, Marseille; Department of Medicine (CF), Gustave Roussy, Villejuif; and Lymphoid Malignancies Unit (CH), Henri Mondor Hospital, AP-HP, Créteil, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000000121DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616278PMC
November 2014

Role of FDG-PET in the implementation of involved-node radiation therapy for Hodgkin lymphoma patients.

Int J Radiat Oncol Biol Phys 2014 Aug 8;89(5):1047-1052. Epub 2014 Jul 8.

Department of Imaging, Institut Curie R. Huguenin Hospital, Saint-Cloud, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2014.04.026DOI Listing
August 2014

Combined linkage and association studies show that HLA class II variants control levels of antibodies against Epstein-Barr virus antigens.

PLoS One 2014 15;9(7):e102501. Epub 2014 Jul 15.

Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale, Paris, France; University Paris Descartes, Sorbonne Paris Cité, Imagine Institute, Paris, France; St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, New York, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0102501PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099326PMC
October 2015

Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial.

J Clin Oncol 2014 Apr 17;32(12):1188-94. Epub 2014 Mar 17.

John M.M. Raemaekers and Richard van der Maazen, Radboud University Medical Center, Nijmegen; Pieternella J. Lugtenburg, Erasmus University Medical Center, Rotterdam; Gustaaf van Imhoff, University Medical Centre Groningen, Groningen, the Netherlands; Marc P.E. André and Thierry van der Borght, Centre Hospitalier Universitaire (CHU) L'Université Catholique de Louvain Mont Godinne, Yvoir; Yolande Lievens, Ghent University Hospital, Ghent; Tiana Raveloarivahy and Catherine Fortpied, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Massimo Federico and Monica Bellei, University of Modena and Reggio Emilia, Modena; Ercole Brusamolino, Istituto Clinico Humanitas, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan; Manuel Gotti, Fondazione IRCCS Policlinico San Matteo, Pavia; Allessandro Re, Spedali Civili Hospital, Brescia; Elisabetta Abruzzese, San Eugenio Hospital, Tor Vergata University, Rome; Annibale Versari, Arcispedale Santa Maria Nuova, IRCCS di Reggio Emilia, Reggio Emilia, Italy; Theodore Girinsky and Christophe Fermé, Institut Gustave Roussy, Villejuif; Reman Oumedaly, CHU Caen; Stephane Bardet, Centre Francois Baclesse, Caen; Pauline Brice, Hôpital Saint-Louis, Paris; Reda Bouabdallah, Institut Paoli Calmette, Marseille; Catherine J. Sebban, Centre Léon Bérard, Lyon; Aspasia Stamatoullas, Centre Henri Becquerel, Rouen; Frank Morschhauser, CHU de Lille, Lille; Pierre Olivier, CHU Nancy, Nancy; Rene-Olivier Casasnovas, CHU de Dijon, Dijon; Michel Meignan, Hôpital Henri Mondor, Creteil, France; and Martin Hutchings, Rigshospitalet, Kopenhagen, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.9298DOI Listing
April 2014

Low-dose radiation treatment in pulmonary mucosa-associated lymphoid tissue lymphoma: a plausible approach? A single-institution experience in 10 patients.

Int J Radiat Oncol Biol Phys 2012 Jul 13;83(3):e385-9. Epub 2012 Mar 13.

Department of Radiation Oncology, Institut Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2012.01.005DOI Listing
July 2012

Management of fertility in patients treated for Hodgkin's lymphoma.

Haematologica 2011 Nov 9;96(11):1692-9. Epub 2011 Aug 9.

Service d’Immuno-Hématologie, Hôpital Saint-Louis, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2011.045856DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208688PMC
November 2011

[Particularities of Hodgkin's lymphoma].

Rev Prat 2010 Jan;60(1):75-9

Service d'onco-hématologie, CHU de Nice, hôpital de l'Archet, 06200 Nice.

View Article

Download full-text PDF

Source
January 2010

Role of imaging to choose treatment.

Cancer Imaging 2005 Nov 23;5 Spec No A:S113-9. Epub 2005 Nov 23.

Department of Medicine, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1102/1470-7330.2005.0032DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1665298PMC
November 2005

ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma.

N Engl J Med 2005 Mar;352(12):1197-205

Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris, Créteil, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa042040DOI Listing
March 2005

Phase II study of concomitant chemoradiotherapy in bulky refractory or chemoresistant relapsed lymphomas.

Int J Radiat Oncol Biol Phys 2005 Feb;61(2):476-9

Department of Radiation Oncology, Institut Gustave Roussy, Villejuif 94805, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2004.06.210DOI Listing
February 2005

TiA1 in advanced-stage classical Hodgkin's lymphoma: no prognostic impact for positive tumour cells or number of cytotoxic cells.

Virchows Arch 2004 Oct 19;445(4):344-6. Epub 2004 Jun 19.

Service Central d'Anatomie et de Cytologie Pathologiques, Hotel-Dieu 1, Place du Parvis Notre Dame, 75181, Paris Cedex 04, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-004-1057-6DOI Listing
October 2004

[Malignant lymphomas].

Rev Prat 2002 Oct;52(15):1711-8

Service d'hématologie, Institut Gustave-Roussy, 94805 Villejuif.

View Article

Download full-text PDF

Source
October 2002